Podcasts
Cardio-Rheumatology Series
The CardioNerds Cardiovascular Prevention Series has delved into the world of inflammation and its role in Cardiovascular Disease. Inflammation is involved both in the pathogenesis and progression of atherosclerosis. Inflammation may be the inciting factor in atherosclerosis, or it may amplify the process driven primarily by other risk factors. Therefore, treating the comorbidities and traditional CVD contributors is key to reducing the vicious inflammatory cycle. This series will take us through it all! It is supported by and unrestricted educational sponsorship from Agepha Pharma. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
Cardio-Rheumatology: The Role of Inflammation in Cardiovascular Disease with Dr. Antonio Abbate
Cardio-Rheumatology: Deciphering Cardiovascular Risk in Patients with Rheumatologic Conditions with Dr. Brittany Weber and Dr. Michael Garshick
SGLT Inhibition Series
The CardioNerds Cardiovascular Prevention Series brings us into the world of SGLT inhibitors. While initially developed as antidiabetic medications, SGLT inhibitors have been shown to be beneficial for cardiovascular and renal outcomes. These benefits result from their on-target glucosuric effects and additional off-target effects. This series will take us through this comprehensive mechanism for Cardiovascular Disease (CVD) prevention and heart failure management, and is supported by unrestricted educational sponorship from Lexicon. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle
SGLT Inhibitors: The Data Supporting SGLT Inhibition with Dr. Muthiah Vaduganathan
SGLT Inhibitors: Clinical Implementation of SGLT Inhibitors with Dr. Alison Bailey
Obesity and GLP-1 RAs
The CardioNerds Cardiovascular Prevention Series, dives into Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease. This series also highlights the impact of obesity on cardiovascular disease risk, differential risk in specific populations, and effective strategies for counseling patients. This series is supported by unrestricted educational sponsorship from Novo Nordisk. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
GLP-1 Agonists: Mechanisms to Applications with Dr. Dennis Bruemmer
Obesity: Obesity & Cardiovascular Disease Risk with Dr. Jaime Almandoz
Obesity: Lifestyle & Pharmacologic Management of Obesity with Dr. Ambarish Pandey
GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire
GLP-1 Agonists: Clinical Implementation of GLP-1 Receptor Agonists with Dr. Neha Pagidapati
Obesity: Procedural Management of Obesity with Dr. Steve Nissen
Cardiovascular Genomics
The CardioNerds Cardiovascular Genomics series is a multi-institutional collaboration made possible by contributions of stellar fellow leads and expert faculty from several programs. The field of Cardiovascular Genomics has advanced tremendously over the past two decades, having a significant clinical impact and changing the perception of the role and scope of genetic testing in several cardiovascular domains. This series is supported by unrestricted educational sponsorship from Illumina, Inc. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
Episode 244. Cardiovascular Genomics: Intro to Cardiovascular Genetics in Electrophysiology with Dr. James Daubert
Episode 246. Cardiovascular Genomics: Genetic Counseling & Family Screening in Arrhythmogenic Cardiomyopathies with Dr. Allison Hays and Dr. Cindy James
Episode 248. Cardiovascular Genomics: Frontiers in Clinical Genetics in Cardiovascular Prevention with Dr. Pradeep Natarajan
Lipid Series
The CardioNerds Lipid Series is a comprehensive series led by series co-chairs Dr. Rick Ferraro, cardiology fellow at The Johns Hopkins Hospital and Dr. Tommy Das, cardiology fellow at The Cleveland Clinic and produced in collaboration with the American Society For Preventive Cardiology (ASPC). This series has been possible by unrestricted support from:
131. Lipids: LDL Physiology & Function with Dr. Peter Toth
139. Lipids: LDL, Cardiovascular Events, & Disparities in Care with Dr. Keith Ferdinand
143. Lipids: (Non)-Fasting LDL & Furious Lipid Lowering with Dr. Alison Bailey
156. Lipids: Triglycerides – Pathophysiology to Clinical Outcomes with Dr. Matthew Budoff
161. Triglycerides - Deep Dive into EPA and DHA with Dr. Erin Michos
194. Lipids: Omega-3 Fatty Acids & The Battle Of The Oils with Dr. Pam Taub
207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth
214. Lipids: Review of Icosapent Ethyl with Dr. Michael Shapiro